From September 26, 2023 to September 30, 2023, the company has repurchased 311,958 shares, representing 0.18% for CNY 35.02 million. With this, the company has completed the repurchase of 311,958 shares, representing 0.18% for CNY 35.02 million under the buyback announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.1 HKD | -0.47% | -1.41% | +4.47% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.47% | 1.92B | |
-4.98% | 182B | |
+2.84% | 112B | |
-2.68% | 68.58B | |
+4.53% | 51.58B | |
+8.00% | 44.24B | |
+9.45% | 43.65B | |
+25.30% | 32.46B | |
+20.94% | 25.99B | |
-0.17% | 25.61B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.